Dual TCR Editing Improves Engineered T Cell Specificity

An online-first peer-reviewed JCI Insight study published November 17 describes CRISPR removal of endogenous TCR-alpha and -beta chains while sparing introduced therapeutic TCR constructs. The authors report more than 90% receptor deletion in primary…













